Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Folic Acid for Vascular Outcome Reduction in Transplantation.

NCT00217100 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00217100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00217100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Folic Acid for Vascular Outcome Reduction in Transplantation.
Lead sponsor
Mayo Clinic
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2004
Completion date
February 28, 2010
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant recipients